Winston Medical Supply Co., Ltd. (TPEX:6817)

Taiwan · Delayed Price · Currency is TWD

80.00

-0.20 (-0.25%)

Mar 10, 2026, 1:11 PM CST

-21.18% (1Y)

Market Cap	1.48B
Revenue (ttm)	724.35M
Net Income (ttm)	134.23M
Shares Out	18.42M
EPS (ttm)	7.26
PE Ratio	11.05
Forward PE	n/a
Dividend	7.00 (8.68%)
Ex-Dividend Date	Jun 13, 2025

Volume	58,195
Average Volume	24,928
Open	80.30
Previous Close	80.20
Day's Range	79.70 - 81.70
52-Week Range	76.60 - 117.50
Beta	0.15
RSI	37.43
Earnings Date	Mar 26, 2026

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, che... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1974

Employees 180

Stock Exchange Taipei Exchange

Ticker Symbol 6817

Full Company Profile

Financial Performance

In 2024, Winston Medical Supply's revenue was 695.08 million, a decrease of -1.97% compared to the previous year's 709.07 million. Earnings were 131.59 million, a decrease of -17.11%.

Financial Statements

News

There is no news available yet.